Details
Stereochemistry | ACHIRAL |
Molecular Formula | C23H31NO2 |
Molecular Weight | 353.4986 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCC(c1ccccc1)(c2ccccc2)C(=O)OCCN(CC)CC
InChI
InChIKey=SNTQPLDRUZOSDP-UHFFFAOYSA-N
InChI=1S/C23H31NO2/c1-4-17-23(20-13-9-7-10-14-20,21-15-11-8-12-16-21)22(25)26-19-18-24(5-2)6-3/h7-16H,4-6,17-19H2,1-3H3
Molecular Formula | C23H31NO2 |
Molecular Weight | 353.4986 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Proadifen is an inhibitor of drug metabolism and cytochrome P450 enzyme system activity. It stimulated the release of prostacyclin (PGI2) from the rabbit aorta, bovine aorta and human umbilical vein in vitro, but had no effect on cultured smooth muscle from the bovine aortic media. In human platelets, proadifen inhibited prostaglandin and thromboxane production induced by A23187, thrombin, and ADP. Proadifen might thus constitute the prototype of a new class of antiplatelet drugs.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL3401 Sources: https://www.ncbi.nlm.nih.gov/pubmed/20966043 |
25.1 µM [EC50] | ||
Target ID: CHEMBL340 Sources: https://www.ncbi.nlm.nih.gov/pubmed/20966043 |
12.6 µM [EC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
PubMed
Title | Date | PubMed |
---|---|---|
Acute cytogenetic effect of benzene on rat bone marrow cells in vivo and the effect of inducers or inhibitors of drug-metabolizing enzymes. | 1992 Dec |
|
[Effect of arachidonic and other fatty acids on the intracellular calcium concentration and calcium signaling in peritoneal macrophages]. | 2001 |
|
Deciphering the plasma membrane hallmarks of apoptotic cells: phosphatidylserine transverse redistribution and calcium entry. | 2001 |
|
Anti-apoptotic and apoptotic action of (-)-deprenyl and its metabolites. | 2001 |
|
Sex-dependent toxicity of a novel acyl-CoA:cholesterol acyltransferase inhibitor, YIC-C8-434, in relation to sex-specific forms of cytochrome P450 in rats. | 2001 Dec |
|
Bradykinin attenuates the [Ca(2+)](i) response to angiotensin II of renal juxtamedullary efferent arterioles via an EDHF. | 2001 Feb |
|
A conformational intermediate between the resting and desensitized states of the nicotinic acetylcholine receptor. | 2001 Feb 16 |
|
Role of copper ions and cytochrome P450 in the vasodilator actions of the nitroxyl anion generator, Angeli's salt, on rat aorta. | 2001 Feb 2 |
|
The role of enzyme induction and inhibition on cypermethrin hepatotoxicity. | 2001 Jul |
|
Perinatal development influences mechanisms of bradykinin-induced relaxations in pulmonary resistance and conduit arteries differently. | 2001 Jul |
|
Site-specific charge interactions of alpha-conotoxin MI with the nicotinic acetylcholine receptor. | 2001 Jun 29 |
|
The role of desensitisation in decay time of miniature endplate currents in frogs Rana ridibunda and Rana temporaria. | 2001 Mar |
|
Phosphoinositide 3-kinase regulates crosstalk between Trk A tyrosine kinase and p75(NTR)-dependent sphingolipid signaling pathways. | 2001 Mar |
|
Cytochrome p450-dependent metabolism of trichloroethylene in rat kidney. | 2001 Mar |
|
[Role of phospholipase A2 and epoxygenase in inhibition of respiration burst in neutrophils by low intensity radiation of extremely high frequency]. | 2001 Mar-Apr |
|
Activation of Galpha s mediates induction of tissue-type plasminogen activator gene transcription by epoxyeicosatrienoic acids. | 2001 May 11 |
|
Microsomal metabolism of ciprofloxacin generates free radicals. | 2001 May 15 |
|
Toxicity of ethacrynic acid in isolated rat hepatocytes. | 2002 Apr |
|
The influence of metabolism on the MAO-B inhibitory potency of selegiline. | 2002 Jan |
|
Paraquat detoxicative system in the mouse liver postmitochondrial fraction. | 2002 Jun 1 |
|
Chemiluminescence associated with the oxidative metabolism of salicylic acid in rat liver microsomes. | 2002 May 20 |
|
Involvement of NO in the endothelium-independent relaxing effects of N(omega)-hydroxy-L-arginine and other compounds bearing a C=NOH function in the rat aorta. | 2002 Nov |
|
The critical role of mitochondrial energetic impairment in the toxicity of nimesulide to hepatocytes. | 2002 Nov |
|
In vivo detection of aflatoxin-induced lipid free radicals in rat bile. | 2002 Oct 10 |
|
Effects of gap junction uncoupling in the gerbil cochlea. | 2002 Sep |
|
In vitro and in vivo formation of aminophenylnorharman from norharman and aniline. | 2002 Sep 30 |
|
Inhibition of cocaine oxidative metabolism attenuates endotoxin potentiation of cocaine mediated hepatotoxicity. | 2002 Sep 30 |
|
Cylindrospermopsin-induced protein synthesis inhibition and its dissociation from acute toxicity in mouse hepatocytes. | 2003 Aug |
|
Antiandrogenic activities of diesel exhaust particle extracts in PC3/AR human prostate carcinoma cells. | 2003 Dec |
|
Effects of cytochrome P450 inhibitors on agonist-induced Ca2+ responses and production of NO and PGI2 in vascular endothelial cells. | 2003 Jun |
|
Concurrent corticosteroid and phenanthrene transformation by filamentous fungus Cunninghamella elegans. | 2003 May |
|
Biotransformation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in peripheral human lung microsomes. | 2003 Sep |
|
Microbial transformations of chalcones: hydroxylation, O-demethylation, and cyclization to flavanones. | 2004 Apr |
|
Chlorpropham induces mitochondrial dysfunction in rat hepatocytes. | 2004 Aug 5 |
|
Pharmacokinetics of baicalin in rats and its interactions with cyclosporin A, quinidine and SKF-525A: a microdialysis study. | 2004 Nov |
|
In vitro confirmation of selegiline N-oxidation by flavin-containing monooxygenase in rat microsome using LC-ESI MS. | 2004 Oct |
|
Metabolism of the alpha,beta-unsaturated ketones, chalcone and trans-4-phenyl-3-buten-2-one, by rat liver microsomes and estrogenic activity of the metabolites. | 2005 Aug |
|
Primary hepatocyte apoptosis is unlikely to relate to caspase-3 activity under sustained endogenous oxidative stress. | 2005 Feb |
|
Identification of cytochrome P450 forms involved in the 4-hydroxylation of valsartan, a potent and specific angiotensin II receptor antagonist, in human liver microsomes. | 2005 Jun |
|
Alteration in endothelial function and modulation by treatment with pioglitazone in rabbit renal artery from short-term hypercholesterolemia. | 2005 Jun |
|
Excretion and metabolism of DA-7867, a new oxazolidinone, in rats. | 2005 Mar |
|
Increased cell-cell adhesion, a novel effect of R-(-)-deprenyl. | 2005 Nov |
|
In vitro inhibitory effect of 1-aminobenzotriazole on drug oxidations in human liver microsomes: a comparison with SKF-525A. | 2005 Oct |
|
Endothelium-dependent and direct relaxation induced by ethyl acetate extract from Flos Chrysanthemi in rat thoracic aorta. | 2005 Oct 3 |
|
Hydroxyeicosatetraenoic acids released through the cytochrome P-450 pathway regulate 3T6 fibroblast growth. | 2006 Dec |
|
Site specificity of agonist-induced opening and desensitization of the Torpedo californica nicotinic acetylcholine receptor. | 2006 Jan 10 |
|
Participation of epoxygenase activation in saikogenin D-induced inhibition of prostaglandin E(2) synthesis. | 2006 Jun |
|
GC-FID determination of cocaine and its metabolites in human bile and vitreous humor. | 2006 May-Jun |
|
Metabolism of pyrene by aquatic crustacean, Daphnia magna. | 2006 Nov 16 |
|
Analytical approach to determine ticlopidine in post-mortem blood. | 2006 Oct 16 |
Patents
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8149992
Effects of local anesthetics-related drugs, proadifen, and quinacrine, on glibenclamide-sensitive K+ currents, were investigated using native Xenopus oocytes. Proadifen and quinacrine suppressed cromakalim-induced/glibenclamide-sensitive K+ currents with IC50 values of 9.8 microM and 4.4 microM, respectively. Inhibitors of either cytochrome P450 or phospholipase A2, which are structurally unrelated to local anesthetics, however, did not affect the K+ currents. Similar results were obtained for Y-26763-induced/glibenclamide-sensitive K+ currents. Proadifen and quinacrine block the glibenclamide-sensitive K+ currents by a mechanism irrelevant to the inhibition of cytochrome P450 or phospholipase A2 in oocytes.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Jun 26 03:15:06 UTC 2021
by
admin
on
Sat Jun 26 03:15:06 UTC 2021
|
Record UNII |
A510CA4CBT
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29574
Created by
admin on Sat Jun 26 03:15:06 UTC 2021 , Edited by admin on Sat Jun 26 03:15:06 UTC 2021
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB10051MIG
Created by
admin on Sat Jun 26 03:15:06 UTC 2021 , Edited by admin on Sat Jun 26 03:15:06 UTC 2021
|
PRIMARY | |||
|
D011335
Created by
admin on Sat Jun 26 03:15:06 UTC 2021 , Edited by admin on Sat Jun 26 03:15:06 UTC 2021
|
PRIMARY | |||
|
CHEMBL282567
Created by
admin on Sat Jun 26 03:15:06 UTC 2021 , Edited by admin on Sat Jun 26 03:15:06 UTC 2021
|
PRIMARY | |||
|
1911
Created by
admin on Sat Jun 26 03:15:06 UTC 2021 , Edited by admin on Sat Jun 26 03:15:06 UTC 2021
|
PRIMARY | |||
|
4910
Created by
admin on Sat Jun 26 03:15:06 UTC 2021 , Edited by admin on Sat Jun 26 03:15:06 UTC 2021
|
PRIMARY | |||
|
302-33-0
Created by
admin on Sat Jun 26 03:15:06 UTC 2021 , Edited by admin on Sat Jun 26 03:15:06 UTC 2021
|
PRIMARY | |||
|
302-33-0
Created by
admin on Sat Jun 26 03:15:06 UTC 2021 , Edited by admin on Sat Jun 26 03:15:06 UTC 2021
|
PRIMARY | |||
|
C84107
Created by
admin on Sat Jun 26 03:15:06 UTC 2021 , Edited by admin on Sat Jun 26 03:15:06 UTC 2021
|
PRIMARY | |||
|
PROADIFEN
Created by
admin on Sat Jun 26 03:15:06 UTC 2021 , Edited by admin on Sat Jun 26 03:15:06 UTC 2021
|
PRIMARY | |||
|
A510CA4CBT
Created by
admin on Sat Jun 26 03:15:06 UTC 2021 , Edited by admin on Sat Jun 26 03:15:06 UTC 2021
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLIC ENZYME -> INHIBITOR |
SELECTIVE
|
||
|
METABOLIC ENZYME -> INHIBITOR |
SELECTIVE
|
||
|
METABOLIC ENZYME -> INHIBITOR |
SELECTIVE
|
||
|
SALT/SOLVATE -> PARENT | |||
|
METABOLIC ENZYME -> INHIBITOR |
SELECTIVE
|
||
|
METABOLIC ENZYME -> INHIBITOR |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |